JPRN-UMIN000027828
Completed
Phase 1
Phase 1 Clinical Trial of Percutaneous Cryoablation for Painful Musculoskeletal Tumor - Phase 1 Trial of Cryoablation for Painful MSK tumor
Overview
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Gunma University Hospital
- Enrollment
- 18
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Association between tumor and pain is unclear 2\) There was a major neurovascular structure in and around the needle access or the planned ablation area 3\) Tumor could not be detected by MRI or CT 4\) Bleeding tendency and coagulation disorder were observed clinically. 5\) Difficult to stop anti\-coagulant drug 6\) Active infection and inflammatory disease 7\) Over 38 degree fever 8\) Patients were confirmed or suspected to be pregnant 9\) Attending physician judged the patient was not appropriate for this study
Investigators
Similar Trials
Active, not recruiting
Phase 1
First-line catheter ablation for early treatment of Persistent (ongoing unless cardioverted) Atrial Fibrillation (AF) – a randomized study comparing isolation of pulmonary veins triggering AF using a Cryoballoon versus antiarrhythmic medication.Persistent symptomatic atrial fibrillationMedDRA version: 25.1Level: LLTClassification code 10081865Term: Cardiac catheter ablationSystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]EUCTR2021-006614-37-SERegion Örebro220
Recruiting
Phase 1
First-line catheter ablation for early treatment of Persistent (ongoing unless cardioverted) Atrial Fibrillation (AF) – a randomized study comparing isolation of pulmonary veins triggering AF using a Cryoballoon versus antiarrhythmic medication.Persistent symptomatic atrial fibrillationMedDRA version: 22.0Level: LLTClassification code: 10081865Term: Cardiac catheter ablation Class: 10042613Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]CTIS2023-505962-28-00Region Oerebro Laen270
Recruiting
Phase 2
Percutaneous Cryoablation for Thoracic MalignanciesThoracic MalignanciesJPRN-jRCTs032230015Asakura Keisuke20
Completed
Phase 2
Safety and Efficacy of Percutaneous Cryoablation for Thoracic MalignanciesPrimary lung cancer, metastatic lung cancer, mediastinal tumor, chest wall tumorJPRN-UMIN000014996School of Medicine, Keio University200
Completed
Not Applicable
Safety cofirmatory study for Percutaneous cryoablation of vascular malformationsvascular malformationJPRN-UMIN000012194Okayama University Hospital9